EBioMedicine · 2020 · 34 citations · 31 references
MedicineCardiologyGeneticsCardiovascular GeneticsCell DifferentiationStem Cell BiologyCardiac Ion ChannelsCardiac Tissue EngineeringCardiac Excitation-contraction CouplingDifferentiationDirected DifferentiationHuman Induced Pluripotent Stem Cell ModelsHuman Stem Cell ModelsRyanodine Receptor MutationsRyanodine Receptor SignalingStem Cell-derived Cardiomyocytes
BACKGROUND: While mutations in the cardiac type 2 ryanodine receptor (RyR2) have been linked to exercise-induced or catecholaminergic polymorphic ventricular tachycardia (CPVT), its association with polymorphic ventricular tachycardia (PMVT) occurring at rest is unclear. We aimed at constructing a patient-specific human-induced pluripotent stem cell (hiPSC) model of PMVT occurring at rest linked to a single point mutation in RyR2. METHODS: Blood samples were obtained from a patient with PMVT at rest due to a heterozygous RyR2-H29D mutation. Patient-specific hiPSCs were generated from the blood samples, and the hiPSC-derived cardiomyocytes (CMs) were generated via directed differentiation. Using CRIPSR/Cas9 technology, isogenic controls were generated by correcting the RyR2-H29D mutation. Using patch-clamp, fluorescent confocal microscopy and video-image-based analysis, the molecular and functional properties of RyR2-H29D hiPSCCMs and control hiPSCCMs were compared. FINDINGS: release in RyR2-H29D hiPSCCMs. RyR2-H29D hiPSCCMs exhibit shorter action potentials, delayed afterdepolarizations, arrhythmias and aberrant contractile properties compared to isogenic controls. The RyR2-H29D mutation causes post-translational remodeling that is fully reversed with isogenic controls. INTERPRETATION: homeostasis, shortened action potentials, arrhythmias and abnormal contractile properties. FUNDING: French Muscular Dystrophy Association (AFM; project 16,073, MNM2 2012 and 20,225), "Fondation de la Recherche Médicale" (FRM; SPF20130526710), "Institut National pour la Santé et la Recherche Médicale" (INSERM), National Institutes of Health (ARM; R01 HL145473) and New York State Department of Health (NYSTEM C029156).
31
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu, David A. Scott, Joshua A. Weinstein et al. · Nature Biotechnology · 2013 · 4.9K citations · Full text
Xiaojun Lian, Jianhua Zhang, Samira M. Azarin et al. · Nature Protocols · 2012 · 1.8K citations · Full text
CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering
Kornel Labun, Tessa G. Montague, James A. Gagnon et al. · Nucleic Acids Research · 2016 · 1.1K citations · Full text